Research & Development



  關小了火焰,熱氣球開始慢慢的下降。   畢竟,阿嬌貴人除過沒有兒子這一個弱點,再無懈可擊!来射吧AV在线播放视频   雲瑯搖搖頭道︰“你李氏的根基在隴西,不在這里,我知道你想的是什麼,現在還不成。雲氏一家在涼州陛下會容忍,如果我們抱團……你自己去想想後果。”caoporn超碰在线视频   “你願意怎麼辦,就怎麼辦吧……”   有幸看到這一幕的藍田張大了嘴巴,雖然她依舊被吊在樹上,卻並不痛苦,相比張安世跟金日霍一,霍三他們,年齡相對小的藍田跟雲哲被霍去病捆的跟兩只蠶一樣,雖然吊在樹上,卻並不痛苦。水莓100视频   他的胸懷就像大海,星空一般寬廣。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo